David Baker’s Technology Transfer and Advisory Roles
Updated 8 January 2022
David Baker is a cofounder, shareholder, or advisor to the following companies.
F = Founder, A = Advisor
Prospect Genomics | 1999 | F | A | Genomics and drug discovery; acquired by Eli Lilly/Structural GenomiX in 2001 |
Bio Architecture Lab | 2008 | A | Developing biofuels and renewable chemicals from macroalgae; no longer active, having licensed their technology to Statoil | |
ARZEDA | 2009 | F | A | Enzyme engineering for agribusiness and fine chemicals |
Pregenen | 2011 | A | Engineering nucleases for genome engineering therapies; acquired in 2014 by Bluebird Bio | |
PVP Biologics | 2012 | F | A | Developing protein therapeutics for celiac disease; acquired by Takeda in 2020 |
Cue Biopharma | 2014 | A | Developing biologic immunotherapies | |
Cyrus Biotech | 2014 | F | A | Cloud-based software for biomolecular design |
Virvio | 2017 | A | Developing broadly-protective influenza therapeutics | |
Icosavax | 2018 | F | A | Developing of protein nanoparticle vaccines for respiratory viruses |
A-Alpha Bio | 2018 | F | A | Accelerating target discovery, library screening, and preclinical drug characterization |
Neoleukin Therapeutics | 2018 | F | A | Developing proteins that activate the immune system to fight cancer |
Sana Biotechnology | 2019 | F | A | Creating and delivering engineered cells as medicine for patients |
Lyell Immunotherapeutics | 2019 | F | A | Developing T-cells to eliminate solid cancers |
Mopac Biologics | 2020 | A | Developing protein therapeutics for gastrointesinal inflammation diseases | |
Monod Bio | 2021 | A | Developing advanced molecular diagnostics | |
Brahma | 2021 | A | Designing bi-specific protein therapeutics | |
Charm | 2021 | A | Applying machine learning to small molecule drug discovery | |
Transycton Bio | 2021 | A | Developing of blood-brain barrier traversal agents |
Rosetta Licensing is managed by UW CoMotion. Royalty proceeds are managed by the Rosetta Commons. Rosetta software has been licensed to numerous non-profit and for-profit organizations.